Strategic Growth and Productivity Program
Search documents
Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings - Colgate-Palmolive (NYSE:CL)
Benzinga· 2025-11-03 19:41
Core Insights - Colgate-Palmolive Company reported third-quarter adjusted earnings per share of 91 cents, exceeding the analyst consensus estimate of 89 cents, with quarterly sales of $5.131 billion, reflecting a 2% increase in net sales [1][3] Group 1: Financial Performance - The company’s third-quarter adjusted earnings per share were 91 cents, beating the consensus estimate of 89 cents [1] - Quarterly sales reached $5.131 billion, aligning with market expectations, and net sales increased by 2% [1] - For 2025, Colgate anticipates net sales growth in the low single digits, impacted slightly by foreign exchange fluctuations [3] Group 2: Strategic Outlook - Colgate is transitioning to a new 2030 strategy and implementing a Strategic Growth and Productivity Program to enhance growth despite global market uncertainties [2] - Organic sales growth is projected at 1%–2%, which includes a ~70 basis points impact from exiting private-label pet sales [3] Group 3: Analyst Ratings and Price Targets - Following the earnings announcement, various analysts adjusted their price targets for Colgate-Palmolive, with Wells Fargo lowering its target from $80 to $77 and Evercore ISI Group from $100 to $94 [4][6] - JP Morgan and Morgan Stanley both maintained an Overweight rating while lowering their price targets to $87 from $88 and $96 respectively [6] - Citigroup maintained a Buy rating but reduced its price target from $105 to $95 [6]
Colgate-Palmolive Analysts Cut Their Forecasts After Q3 Earnings
Benzinga· 2025-11-03 19:41
Core Insights - Colgate-Palmolive Company reported third-quarter adjusted earnings per share of 91 cents, surpassing the analyst consensus estimate of 89 cents, with quarterly sales of $5.131 billion, reflecting a 2% increase in net sales [1][3] Financial Performance - The company’s third-quarter adjusted earnings per share were 91 cents, beating the consensus estimate of 89 cents [1] - Quarterly sales reached $5.131 billion, aligning with market expectations, and net sales increased by 2% [1] - For 2025, Colgate anticipates net sales growth in the low single digits, impacted slightly by foreign exchange [3] Strategic Outlook - Colgate is transitioning to a new 2030 strategy and implementing a Strategic Growth and Productivity Program, aiming to reaccelerate growth amid global market uncertainties [2] - Organic sales growth is projected at 1%–2%, with approximately 70 basis points impact from exiting private-label pet sales [3] Analyst Ratings and Price Targets - Wells Fargo maintained an Underweight rating, lowering the price target from $80 to $77 [6] - Evercore ISI Group maintained an Outperform rating, reducing the price target from $100 to $94 [6] - JP Morgan and Morgan Stanley both maintained Overweight ratings, with price targets adjusted from $88 to $87 and from $96 to $87, respectively [6] - Citigroup maintained a Buy rating, significantly lowering the price target from $105 to $95 [6]
Colgate-Palmolive(CL) - 2025 Q3 - Earnings Call Presentation
2025-10-31 12:30
Financial Performance & Guidance - Net sales increased by 20%[18] - Organic sales increased by 04%, led by oral care, including a 08% negative impact from lower private label pet sales[18] - The company returned $21 billion to shareholders year to date[31] - Net sales growth is expected to be up low single digits, including a flat to low-single-digit negative impact from foreign exchange[24] - Organic sales growth is now expected to be 1% to 2%, roughly in line with year-to-date organic sales growth of 12%, including an approximately 70 basis point impact from exit from private label pet sales[25] - The company expects approximately $75 million in tariff costs for 2025[26] Strategic Initiatives - The company announced a new three-year productivity program to drive future top and bottom line growth and support the Company's 2030 strategy[20] - The Strategic Growth and Productivity Program is projected to result in cumulative pre-tax charges totaling between $200 and $300 million over the course of the three-year program[21] - Colgate Bright Smiles, Bright Futures achieved a new milestone - reaching approximately 2 billion children and their families worldwide since 1991[18] Market Share - Global toothpaste market share was up 10 basis points on a volume basis year to date[18] - Global manual toothbrush market share was up 50 basis points on a volume basis year to date[18]